• Department of Cardiothoracic Surgery, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200092, P.R.China;
LI Guoqing, Email: liguoqing@xinhuamed.com.cn
Export PDF Favorites Scan Get Citation

Objective  To summarize the clinical experience of treating adults with pectus excavatum by newly modified orthopedicsteel plate and Nuss procedure. Methods  The clinical data of 190 adults with pectus excavatum treated by newly modified Nuss procedure in Xinhua Hospital affiliated to Shanghai Jiaotong University School of Medicine from January 2011 to June 2016 were collected. There were 151 males and 39 females aged 21.80±3.96 years ranging from 18 to 45 years. The therapeutic efficacy, Haller index and the lung function index were also analyzed. Results  All patients recovered well after the operation. Two orthopedic steel plates were implanted in 12 patients. Pneumothorax was found in 7 patients postoperatively and 2 of them was treated by puncture extraction. There were 5 patients with poor healing of incision and all of them were healed after the debridement. Other complications such as steel plate shift was found in 2 patients. Both of them recovered after the reoperation. The duration of operation was 36–65 min. The intraoperative blood loss was 5–20 ml. Postoperative hospital stay was 4–7 days. Haller and lung function index improved after the operation (P<0.001). Conclusion  It is effective and safe to treat the pectus excavatum by newly modified orthopedic steel plate and Nuss procedure in adult patients.

Citation: HU Fengqing, WANG Lei, WANG Mingsong, MEI Ju, LI Guoqing. Surgical treatment of 190 adults with pectus excavatum by newly modified orthopedic steel plate. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2018, 25(8): 687-690. doi: 10.7507/1007-4848.201709006 Copy

  • Previous Article

    Status quo of enhanced recovery after surgery in different regional thoracic surgery in the mainland of China
  • Next Article

    Magnetic nanoparticle method for detecting circulating tumor cells of lung cancer: A pilot study